Hypercholesterolemia: Chemical Aspect of Approach
Six of thirty currently known biological targets for treating hyperlipidemia were selected and considered. All of the chemical structures under study are divided into two classes with different mechanisms of their activity: cholesterol biosynthesis blockers (HMG-CoA reductase and squalene 2,3-oxide-lanosterol cyclase inhibitors) and regulators of cholesterol transformations in the organism (PPARα and PPARα/γ agonists, inhibitors of intestinal absorption of cholesterol, cholesteryl ester transfer protein (CETP) inhibitors, and regulators of low-density-lipoprotein receptor (LDLR) expression).
Keywords: " structure-activity" relationships; CETP inhibitors; HMG-CoA reductase; PPARα and PPARα/γ agonists; cholesterol-regulating agents; inhibitors of intestinal absorption of cholesterol; regulators LDLR expression; squalene 2,3-oxide-lanosterol cyclase inhibitors
Document Type: Research Article
Publication date: 2011-09-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.